Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

HRTS vs. RYHIX: which is better?

Bottom line

HRTS vs RYHIX: the short answer

HRTS (Tema Heart & Health ETF) and RYHIX (Health Care Fund) are both etfs.

But RYHIX is far broader, holding 135 positions to 45 for HRTS, so beyond the top names it adds exposure HRTS doesn't have.

HRTS is cheaper at 0.75% vs 1.38% — a difference of $63 a year per $10,000 invested.

Over one year, HRTS returned +23.6% vs +14.4% for RYHIX.

Updated Nov 19, 2026

HRTS vs RYHIX side by side

HRTSRYHIX
TypeETFMutual fund
Fund familyInnovatorGuggenheim
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.75%1.38%
Annual cost per $10k$75$138
10-yr cost on $10k (prospectus)$1,168$1,709
Max front loadNone—
12b-1 fee0%0%
1-yr return+23.6%+14.4%
5-yr return (annualized)—+5.1%
10-yr return (annualized)—+7.9%
Best quarter+15.8%+18.7%
Worst quarter−12.4%−14.4%
Net assets (fund)$51.9M$19.4M
Number of holdings45135
Portfolio turnover4%244%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearHRTSRYHIXDifference
2025+23.6%+14.4%+9.2%
2024+3.6%+0.6%+3.0%

Source: Fund prospectus bar charts

Holdings overlap

15 of HRTS's top 25 holdings also appear in RYHIX's top 25.

Shared top holdings
HoldingHRTSRYHIX
Eli Lilly & Co11.52%3.63%
UnitedHealth Group Inc5.24%2.22%
Merck & Co Inc4.27%2.04%
Thermo Fisher Scientific Inc3.97%1.61%
Johnson & Johnson3.59%2.88%
Gilead Sciences Inc3.43%1.39%
Vertex Pharmaceuticals Inc2.93%1.34%
Danaher Corp2.66%1.30%
Abbott Laboratories2.61%1.42%
AbbVie Inc2.40%2.52%
Bristol-Myers Squibb Co2.09%1.22%
Amgen Inc1.91%1.56%
Edwards Lifesciences Corp1.75%0.84%
McKesson Corp1.71%1.05%
Regeneron Pharmaceuticals Inc1.67%0.90%

Source: SEC Form N-PORT

HRTS top 10

  1. Eli Lilly & Co — 11.52%
  2. UnitedHealth Group Inc — 5.24%
  3. Novo Nordisk A/S — 5.24%
  4. Roche Holding AG — 4.50%
  5. Merck & Co Inc — 4.27%
  6. AstraZeneca PLC — 4.00%
  7. Thermo Fisher Scientific Inc — 3.97%
  8. Johnson & Johnson — 3.59%
  9. Gilead Sciences Inc — 3.43%
  10. Novartis AG — 3.38%

RYHIX top 10

  1. Eli Lilly & Company — 3.63%
  2. Johnson & Johnson — 2.88%
  3. Abbvie Inc — 2.52%
  4. Unitedhealth Group Inc — 2.22%
  5. Merck & Company Inc — 2.04%
  6. Thermo Fisher Scientific Inc — 1.61%
  7. Amgen Inc — 1.56%
  8. Abbott Laboratories — 1.42%
  9. Gilead Sciences Inc — 1.39%
  10. Vertex Pharmaceuticals Inc — 1.34%

FAQ

What is the difference between HRTS and RYHIX?
HRTS (Tema Heart & Health ETF) and RYHIX (Health Care Fund) are both etfs. But RYHIX is far broader, holding 135 positions to 45 for HRTS, so beyond the top names it adds exposure HRTS doesn't have.
Which is cheaper, HRTS or RYHIX?
HRTS has the lower expense ratio (0.75%).
Should I own both HRTS and RYHIX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.